Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure

Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...

September 27, 2023 | Wednesday | News
Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®

“We are thrilled to receive marketing approval for AVT04 in Japan, which will be Alvotech’s second marketed biosimilar,” said Robert Wess...

September 26, 2023 | Tuesday | News
Japan Approves EPKINLYTM as First Bispecific Antibody for R/R LBCL

Subcutaneous EPKINLYTM (epcoritamab) is the first and only bispecific antibody approved in Japan to treat adult patients with certain types of relapsed/r...

September 26, 2023 | Tuesday | News
MGI Partners with Gencell to Expand Genomics in Latin America

The healthcare landscape in Latin America is currently a worldwide priority. Factors such as increasing awareness of precision medicine, the growing preval...

September 25, 2023 | Monday | News
European Commission Approves ORSERDU® for ER+ Breast Cancer with ESR1 Mutation

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

September 14, 2023 | Thursday | News
Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based gl...

September 21, 2023 | Thursday | News
Natera Expands I-SPY 2 Collaboration for Signatera™ in Breast Cancer Neoadjuvant Study

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing,  announced a new study as part of the I-SPY 2 trial, sponsored and operated by ...

September 15, 2023 | Friday | News
Eurofins Genomics Adopts Olink® Tech for Precision Medicine Advancement

Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields...

September 13, 2023 | Wednesday | News
Thermo Fisher's Next-Gen Gibco™ CTS™ Dynabeads™ Advance Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, its nex...

September 08, 2023 | Friday | News
Cell BioEngines Licenses Patent for Oncology Cell Transplantation

Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at Mount Sinai, in New ...

September 08, 2023 | Friday | News
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

The companies will collaborate to apply ShapeTX’s AAVid™ capsid discovery platform and transgene engineering technology along with Otsuka&...

September 08, 2023 | Friday | News
Bristol Myers Squibb Signs $50M Deal to Address Immune-Mediated Diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...

September 07, 2023 | Thursday | News
Exosomes functionally deliver siRNAs in vivo to repress tumor growth

Over the past few years, exosomes have gained significant attentions as a promising drug delivery vehicle in both academic and biomedical industry circles....

September 06, 2023 | Wednesday | News
Novozymes and Bactolife Partner to Cut Weaner Pig Antibiotic Use

Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development and commercialization agreement to finish development and l...

September 05, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close